Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Ausbüttel is a medium-sized, family-owned German healthcare company specializing in high-quality wound care and medical products. Founded in 1920 and headquartered in Dortmund, the company operates primarily through its prominent brands DRACO and Piratoplast. DRACO provides a comprehensive portfolio of modern wound care solutions, including hydrocolloids, foam dressings, and alginates, alongside traditional bandages and plasters. Piratoplast focuses on specialized eye patches used in the treatment of amblyopia in children. The company is a key supplier to the German pharmacy and clinical markets, emphasizing cost-effective and clinically effective medical solutions. Dr. Ausbüttel is recognized for its long-standing commitment to social responsibility and sustainable business practices within the DACH region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Ausbüttel Pharma.